Found: 24
Select item for more details and to access through your institution.
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.
- Published in:
- Scientific Data, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41597-022-01560-7
- By:
- Publication type:
- Article
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.872756
- By:
- Publication type:
- Article
Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075945
- By:
- Publication type:
- Article
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07578-z
- By:
- Publication type:
- Article
Live Organoid Cyclic Imaging.
- Published in:
- Advanced Science, 2024, v. 11, n. 14, p. 1, doi. 10.1002/advs.202309289
- By:
- Publication type:
- Article
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.664236
- By:
- Publication type:
- Article
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.640910
- By:
- Publication type:
- Article
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.669071
- By:
- Publication type:
- Article
PATH-40. TARGETED NEXT GENERATION SEQUENCING (NGS) OF YOUNG ADULTS WITH ISOCITRATE-DEHYDROGENASE WILD-TYPE GLIOBLASTOMA (IDH-WT GBM) REVEALS NEGATIVE PROGNOSTIC IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR AMPLIFICATION (EGFRAMP).
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi167, doi. 10.1093/neuonc/noy148.696
- By:
- Publication type:
- Article
Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 532, p. 1, doi. 10.1126/scitranslmed.aay7522
- By:
- Publication type:
- Article
Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice.
- Published in:
- Veterinary Pathology, 2024, v. 61, n. 4, p. 664, doi. 10.1177/03009858231222216
- By:
- Publication type:
- Article
Optimizing CAR-T Therapy for Glioblastoma.
- Published in:
- Molecular Diagnosis & Therapy, 2023, v. 27, n. 6, p. 643, doi. 10.1007/s40291-023-00671-0
- By:
- Publication type:
- Article
Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150271
- By:
- Publication type:
- Article
Intraoperative hypertensive crisis due to a catecholamine-secreting esthesioneuroblastoma.
- Published in:
- Head & Neck, 2015, v. 37, n. 6, p. E74, doi. 10.1002/hed.23907
- By:
- Publication type:
- Article
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 2, p. 321, doi. 10.1007/s11060-019-03298-6
- By:
- Publication type:
- Article
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 141, n. 2, p. 421, doi. 10.1007/s11060-018-03050-6
- By:
- Publication type:
- Article
SHP2 regulates proliferation and tumorigenicity of glioma stem cells.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 487, doi. 10.1007/s11060-017-2610-x
- By:
- Publication type:
- Article
The role of STAT3 activation in modulating the immune microenvironment of GBM.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 3, p. 359, doi. 10.1007/s11060-012-0981-6
- By:
- Publication type:
- Article
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
EGFR, the Lazarus target for precision oncology in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2035, doi. 10.1093/neuonc/noac204
- By:
- Publication type:
- Article
Establishment and characterization of a primary human chordoma xenograft model.
- Published in:
- Journal of Neurosurgery, 2012, v. 116, n. 4, p. 801, doi. 10.3171/2011.12.jns111123
- By:
- Publication type:
- Article
Neuroimaging Highlight.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55072-y
- By:
- Publication type:
- Article
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55072-y
- By:
- Publication type:
- Article